Skip to main content
logo
CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.1950
-0.0050 (-2.50%)
Sep 8, 2026, 1:27 PM EST

CytoDyn Cash Flow Statement

Millions USD. Fiscal year is Jun - May.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Net Income
-42.73.75-49.84-79.82-210.82
Depreciation & Amortization
0.020.020.030.180.78
Other Amortization
-0.411.652.23.05
Stock-Based Compensation
1.631.612.424.286.24
Other Operating Activities
1.931.6323.1149.26127.81
Change in Inventory
----2.06
Change in Accounts Payable
17.87-11.3310.77-3.1-2.71
Change in Other Net Operating Assets
4.01-4.840.891.9-4.13
Operating Cash Flow
-17.25-8.77-10.98-25.11-77.72
Operating Cash Flow Growth
-----

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Long-Term Debt Issued
--2.310.9-
Long-Term Debt Repaid
-0.14-0.71---
Total Debt Repaid
-0.14-0.71---
Net Debt Issued (Repaid)
-0.14-0.712.310.9-
Issuance of Common Stock
16.471.199.4426.2342.62
Other Financing Activities
0.8710.38-2.815.39
Financing Cash Flow
17.210.8511.7529.9348.01

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Net Cash Flow
-0.052.090.774.82-29.71

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Free Cash Flow
-17.25-8.77-10.98-25.11-77.72
Free Cash Flow Growth
-----
Free Cash Flow Margin
-----29219.17%
Free Cash Flow Per Share
-0.01-0.01-0.01-0.03-0.12
Levered Free Cash Flow
-0.77-4.3-43.19-31.93-102.87
Unlevered Free Cash Flow
0.8-1.67-39.28-24.44-90.8

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 May '25 May '24 May '23 May '22
Cash Interest Paid
0.020.030.050.020.06
Change in Working Capital
21.87-16.1711.66-1.2-4.78